Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
27.8% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
25.6% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
5.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Nightingale Health Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
New US And Singapore Labs Will Improve Healthcare Efficiency
Key Takeaways Nightingale Health's innovative disease detection from a single blood sample and international deals could boost global market penetration and revenue expansion. Strategic vertical integration, low burn rate, and possible stock listings aim to enhance operational efficiency, financial stability, and investor interest.
View narrative
€2.90
FV
18.4% undervalued
intrinsic discount
50.78%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Stereotaxis
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Robotic Catheters And Digital Surgery Will Boost Adoption
Key Takeaways Expanding proprietary product portfolio, regulatory approvals, and digital platform integration position Stereotaxis for greater market adoption, recurring revenue, and margin improvement. Strategic investments in sales and multi-application platforms broaden market reach and support sustainable growth in volumes, earnings, and profitability.
View narrative
US$4.50
FV
43.6% undervalued
intrinsic discount
40.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Full House Resorts
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
New High-Quality Venues Will Expand Regional Gaming Markets
Key Takeaways New property openings, operational efficiencies, and data-driven marketing are expected to drive revenue growth, margin expansion, and improved guest retention. Expanded regional footprint and flexibility in entering emerging markets position the company for sustained growth despite broader economic uncertainties.
View narrative
US$5.00
FV
33.6% undervalued
intrinsic discount
7.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Clarus
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Global Outdoor Market Expansion Will Unlock Long-Term Value
Key Takeaways International expansion, product innovation, and rising global demand are positioning core brands for sustained revenue growth and higher average selling prices. Operational streamlining, cost reductions, and financial discipline are improving margins and providing flexibility for further investment and long-term earnings growth.
View narrative
US$4.25
FV
24.5% undervalued
intrinsic discount
3.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
ADC Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expanding ZYNLONTA Trials Will Broaden DLBCL Treatment Options
Key Takeaways Expanding ZYNLONTA into earlier lines of DLBCL through trials could significantly boost revenue by accessing a larger patient population. Strategic advancements and research collaborations are poised to enhance profitability and strengthen long-term growth prospects.
View narrative
US$8.20
FV
67.3% undervalued
intrinsic discount
31.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
FiscalNote Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
PolicyNote Platform Will Boost Engagement Despite Revenue Headwinds
Key Takeaways Introducing PolicyNote aims to boost customer retention and revenue growth by enhancing client engagement and leveraging advanced features. Streamlining operations and simplifying the product portfolio target improved EBITDA margins and financial stability.
View narrative
US$2.85
FV
80.5% undervalued
intrinsic discount
-9.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
4 days ago
author updated this narrative
NX Filtration
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
New Dutch Factory And OEM Partnerships Will Fuel Market Expansion
Key Takeaways The new factory in the Netherlands and strengthened OEM partnerships are set to significantly boost production, operational efficiency, and future revenue growth. Global sales expansion and innovative technology investments focus on water scarcity solutions, enhancing market penetration and bolstering NX Filtration's ESG reputation.
View narrative
€4.24
FV
23.3% undervalued
intrinsic discount
68.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
4 days ago
author updated this narrative
MacroGenics
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
LORIKEET And LINNET Trials Will Spur Advances Amid Liquidity Risks
Key Takeaways Future revenue growth potential hinges on successful trial outcomes and product approvals in ongoing and upcoming clinical studies. A robust pipeline and financial sustainability support continued R&D efforts, reinforcing prospects for growth if new treatments prove effective.
View narrative
US$4.20
FV
65.0% undervalued
intrinsic discount
-19.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
4 days ago
author updated this narrative
Southland Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Shands And RFK Bridge Projects Will Drive Future Progress
Key Takeaways A substantial backlog and new core projects are set to drive revenue growth and enhance margin profiles as they mature. Expansion into alternative delivery projects and infrastructure funding creates opportunities for improved revenue and margins amid a solid financial environment.
View narrative
US$5.50
FV
18.4% undervalued
intrinsic discount
8.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies